NSE filing, NSE: PAR. Summary written from the filing by ALFA Finder's alert engine.
Par Drugs & Chemicals Ltd: key numbers
- Share price
- ₹120.60
- Market cap
- ₹148.4 Cr
- Revenue (annual)
- ₹103.7 Cr
- Net profit (annual)
- ₹13.11 Cr
- P/E (TTM)
- 10.2×Sector 46.1×
- Promoter holding
- 73.41%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Par Drugs & Chemicals Ltd
All →Par Drugs & Chemicals Board Meeting Date
Par Drugs and Chemicals Limited will hold a board meeting on October 29, 2026, to consider and approve its half-yearly unaudited financial results.
Par Drugs & Chemicals Other Announcement
The company submitted the routine Regulation 74(5) compliance certificate from its RTA regarding share dematerialization for the quarter ended September 30, 2026.
Par Drugs & Chemicals Management Change
Par Drugs re-appointed its statutory auditor and executive director/CEO. These appointments were approved at the company's 27th Annual General Meeting.
Par Drugs & Chemicals Annual General Meeting
Par Drugs and Chemicals Limited held its 27th Annual General Meeting on September 26, 2026. Management reviewed the company's financial performance and business affairs during the session.
Par Drugs & Chemicals Other Announcement
Par Drugs and Chemicals Limited is notifying shareholders about access to the FY 2025-26 Annual Report and 27th AGM notice via web-link.
Par Drugs & Chemicals Management Change
Par Drugs and Chemicals Limited has re-appointed M/s. Siddhpura & Co. as Internal Auditor and M/s. Maulin Shah & Associates as Cost Auditor.
Other legal & regulatory announcements
All →Bharti Airtel Legal & Regulatory
Bharti Airtel disclosed a DoT Karnataka penalty of Rs. 2,14,000 for subscriber verification norm violations. The company will pay the penalty without contest.
- Value
- ₹0.02 Cr
Bajaj Electricals Legal & Regulatory
Bajaj Electricals received two adverse GST appellate orders upholding a total demand of Rs. 9.36 Crore for FY 2018-19. The Company is evaluating further legal remedies including a tribunal appeal.
- Value
- ₹9.36 Cr
Kalpataru Projects International Legal & Regulatory
KPIL received a GST order demanding INR 6.76 Crore penalty for FY 2018-19 and 2020-21. The company plans to appeal before the first Appellate Authority.
- Value
- ₹6.76 Cr
Kovai Medical Center and Hospital Legal & Regulatory
Kovai Medical Center received a customs adjudication order for ₹2.11 Crore duty, fine and penalty. The order concerns non-fulfilment of post-importation conditions on duty-free equipment imports.
- Value
- ₹2.11 Cr
SKM Egg Products Export (India) Legal & Regulatory
SKM Egg Products received a Registrar of Companies penalty of about Rs.0.024 Crore for delayed MR-1 filings on director reappointment. The company states no material financial impact.
- Value
- ₹0.02 Cr
Coromandel International Legal & Regulatory
Coromandel International received a Deputy Commissioner (Appeal) GST order-in-appeal for FY 2019-20 confirming ineligible input tax credit demand. The company will appeal before GSTAT and expects no significant financial impact.
- Value
- ₹0.18 Cr